★ PTSDIY · Field Manual ★ Part V ★
Chapter 26
Emerging treatments
What's on the horizon
FM 26-EMR-201Status as of Oct 2026
26-1.Mission brief
Some of the most talked-about PTSD treatments are still being tested. This chapter separates what's available from what's hype, and dates every claim, because this field is moving fast.
Date stamp — Status current as of October 2026. Check the PTSDIY site for updates before acting on anything here.
26-2.Intel — the landscape
| Treatment | Status | Notes |
|---|---|---|
| MDMA-assisted therapy | Not approved | FDA declined in 2024. A new application was filed in summer 2026 and is under review. VA/DoD-funded trials continue. |
| Psilocybin-assisted therapy | Investigational | Trials ongoing; not approved for PTSD. |
| TMS (magnetic stimulation) | Approved for depression | Used off-label for PTSD; early evidence is mixed but encouraging. |
| Intensive outpatient programs | Available now | Two- to three-week programs of daily PE or CPT, with strong results. |
26-3.Field procedures — joining a trial
| 01 | Search ClinicalTrials.govFilter by PTSD and your location. |
| 02 | Read the eligibilityMany trials exclude recent substance use or certain medications. |
| 03 | Ask about follow-upGood trials include preparation and integration therapy. |
26-4.Rules of engagement
Warning — Underground or unsupervised psychedelic use carries real risks: dangerous drug interactions, adulterated substances, and psychological crises without support. If you're considering it, talk to a doctor first.
26-5.Common faults & corrections
| ✕ | Fault: Waiting for the breakthroughCorrection: Proven treatments work now. Don't put recovery on hold for one that might be approved. |
PTSDIY · FM 26-EMR-201 · Part V26